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D I S E A S E S  A N D  D I S O R D E R S
Tdp1 protects from topoisomerase 1–mediated 
chromosomal breaks in adult zebrafish but is 
dispensable during larval development
Ringaile Zaksauskaite1, Ruth C Thomas1,2, Freek van Eeden1,2*, Sherif F. El-Khamisy1,3*
Deficiency in the DNA end-processing enzyme, tyrosyl-DNA phosphodiesterase 1 (TDP1), causes progressive neuro-
degeneration in humans. Here, we generated a tdp1 knockout zebrafish and confirmed the lack of TDP1 activity. In 
adulthood, homozygotes exhibit hypersensitivity to topoisomerase 1 (Top1) poisons and a very mild locomotion 
defect. Unexpectedly, embryonic tdp1−/− zebrafish were not hypersensitive to Top1 poisons and did not exhibit 
increased Top1-DNA breaks. This is in contrast to the hypersensitivity of Tdp1-deficient vertebrate models reported 
to date. Tdp1 is dispensable in the zebrafish embryo with transcript levels down-regulated in response to Top1-
DNA damage. In contrast, apex2 and ercc4 (xpf) transcripts were up-regulated. These findings identify the tdp1−/− 
zebrafish embryo as the first vertebrate model that does not require Tdp1 to protect from Top1-DNA damage and 
identify apex2 and ercc4 (xpf) as putative players fulfilling this role. It highlights the requirement of distinct DNA 
repair factors across the life span of vertebrates.
INTRODUCTION
Defects in DNA repair are linked to a variety of human disorders 
(1, 2). DNA repair protects from cancer, neurological disorders, 
immunodeficiency, and premature aging. One example is spinocer-
ebellar ataxia with axonal neuropathy 1 (SCAN1), which is caused 
by an autosomal recessive mutation in tyrosyl-DNA phosphodies-
terase 1 (TDP1), primarily causing progressive cerebellar atrophy, 
neuropathy, and distal muscle weakness (3). This leads to the develop-
ment of an ataxic gait, areflexia, dysarthria, loss of vibration sensation, 
and confinement to a wheelchair by early adulthood. TDP1 repairs 
a variety of damaged 3′ termini, namely 3′-phosphoglycolate, 
3′-deoxyribose phosphate, 3′-histidine, and, importantly, 
3′-topoisomerase 1 cleavage complexes (Top1-CCs) (4–7). Studies 
in yeast and chicken, as well as studies using recombinant human 
TDP1, have shown that TDP1 also plays a role in the repair of 
5′-phosphotyrosyl lesions, caused by Top2-CCs (8, 9). Top1-CCs 
occur because of the abortive activity of topoisomerase 1 (TOP1).
TOP1 relieves torsional stresses of DNA by transiently nicking 
one DNA strand and creating a phosphodiester bond between its 
active site tyrosine and the DNA, allowing controlled rotation of the 
nicked strand (10). The topoisomerase-DNA intermediate is called 
a TOP1-CC and can turn into a persistent single-strand break or 
double-strand break (DSB) because of collision with replication, 
transcription machinery, or the presence of proximal oxidative or 
bulky lesions (11–15). Out of all the lesions that TDP1 repairs, 
TOP1-CCs are the preferred substrates and have received the most 
interest because of their antireplicative properties, which can be 
used in cancer therapy by employing agents that stabilize TOP1-
CCs, such as camptothecin (CPT) and its water-soluble analog 
topotecan (TPT) (16).
TDP1 cleaves the phosphodiester bond between the DNA and 
topoisomerase 1 by first generating a TDP1-DNA intermediate, 
which is then hydrolyzed using the histidine-493 active site (6, 17). 
The H493R mutation in SCAN1 not only reduces TDP1 activity by 
25-fold but also causes the accumulation of TDP1-DNA complexes; 
thus, it may have neomorphic properties (18, 19). It is unclear 
whether the SCAN1 phenotype arises because of a reduction in 
TDP1 activity and, thus, elevated TOP1-CC levels, accumulation of 
TDP1-DNA complexes, or both.
Tdp1−/− mouse models were generated by three separate groups 
with some evidence of mild cerebellar degeneration (19–21). Notably, 
Atm−/− mice also do not adequately recapitulate the most notable 
clinical phenotype in ataxia telangiectasia, which is neurodegenera-
tion, raising the question whether mouse is the ideal organism to 
model human neurological disorders (22). In an attempt to study 
the physiological function of TDP1 at the whole organismal level, 
we used CRISPR-Cas9 to generate a zebrafish tdp1−/− model. 
Zebrafish are vertebrates with high genetic similarity to humans 
that offer external development, high fecundity, and larval trans-
parency and reach sexual maturity quickly, allowing large-scale 
studies that were not previously possible in mammalian models. 
Here, we describe the zebrafish tdp1−/− model and characterize its 
phenotype. We show that adult, but not embryonic, tdp1−/− zebrafish 
exhibit hypersensitivity to TOP1 poisons and a very mild behavioral 
defect. Our findings indicate that in the embryos, tdp1 is down- 
regulated and, instead, apex2 and ercc4 (xpf) are up-regulated in 
response to Top1 inhibition. This model will be a valuable tool for 
the generation of a humanized SCAN1 zebrafish and will form the 
basis for genetic and chemical modifier screens to unravel new 
physiologically relevant TOP1-mediated repair mechanisms and 
adjuvants for TOP1-targeting chemotherapeutics.
RESULTS
Generation and validation of tdp1−/− zebrafish
Similar to mammals, zebrafish contain a single tdp1 ortholog. The 
zebrafish tdp1 gene encodes a protein of 615 amino acids with a 
high degree of similarity to its human counterpart (Fig. 1, A and B). 
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All five DNA-interacting amino acids and six catalytic residues are 
conserved. Whole-mount in situ hybridization revealed ubiquitous 
tdp1 expression with an emphasis in the head in 24-hpf (hours 
post-fertilization) wild-type embryos (Fig. 1C).
Two deletion alleles, SH475 and SH476, were generated in exon 2 
of the zebrafish tdp1 gene using the CRISPR-Cas9 system (Fig. 2, A 
to C). SH475 and SH476 contained a 4– and 5–base pair (bp) dele-
tion, respectively, which both cause a frameshift and result in a pu-
tative early stop codon 21 and 6 amino acids downstream of the 
deletion, respectively (Fig. 2C). The founders carrying these alleles 
were out-crossed to a wild-type strain to create tdp1−/+ zebrafish 
(tdp1SH475/+ and tdp1SH476/+), which were then crossed to produce 
tdp1SH475/SH476 and tdp1SH475/SH475 (hereafter referred to as tdp1−/−) 
fish. Tdp1−/− animals were born at expected Mendelian ratios, had 
normal longevity, and appeared to be in good health (Fig. 2D). To 
confirm the loss of Tdp1 protein in the mutants, we used a TDP1 
biochemical activity assay. In this assay, a labeled oligonucleotide 
harboring a 3′ phosphotyrosyl moiety (3′-PY) is incubated with 
whole embryo lysate. If active TDP1 is present, then a band shift on 
a DNA sequencing gel is observed (Fig. 2E). The band shift denotes 
the cleavage of the phosphodiester bond between the phosphate 
and tyrosine, which mimics the bond linking the tyrosine residue in 
TOP1 and the 3′ terminus of DNA. We incubated lysates from 4-dpf 
(days post-fertilization) embryonic and adult fish with such an 
oligonucleotide and did not observe a band shift in tdp1−/− samples, 
confirming that Tdp1 activity has been abolished by the mutation at 
4 dpf (Fig. 2, F and G).
Adult, but not embryonic, tdp1−/− zebrafish exhibit a very 
mild locomotion defect
To assess potential progressive neurodegeneration in tdp1−/− zebrafish, 
behavioural analysis using a camera system was performed in tdp1−/− 
fish and tdp1WT siblings every 2 months from 14 to 24 months of age 
(Fig. 3 and fig. S1). Parameters measured were the number of times each 
of the three speeds (low, medium, and high) were initiated (speed count), 
the length of time spent swimming at each speed (speed duration), total 
distance, and average speed. We defined low speed as <30 mm/s, 
medium speed as 30 to 60 mm/s, and high speed as 60 mm/s or 
above. Data analysis revealed a modest but significant reduction in 
two of six time points for low speed count, medium speed duration, 
and count in the tdp1−/− fish in comparison to wild types (Fig. 3). 
Although an overall trend of reduced locomotion was observed 
across all parameters, the difference between tdp1−/− fish and their 
wild-type siblings in low speed count, medium speed, high speed 
duration and count, total distance traveled, and average speed did 
not reach statistical significance (Fig. 3 and fig. S1, A and B). These 
data suggest a trend of mildly impaired locomotion across all pa-
rameters tested.
The fish were also subjected to swim tunnel analysis at 19 months 
of age (fig. S1, C to F). In this assay, the fish were placed in a tube 
filled with water and an increasing current was applied against them. 
Endurance of the fish can be determined by calculating the critical 
swimming speed, Ucrit, as described in Materials and Methods. Crit-
ical swimming speed is dependent on the percentage of fish still 
swimming at each flow rate, which was not affected in tdp1−/− fish 
(fig. S1D). Since the weight and length of the fish could affect the 
result, these parameters were measured among the fish tested and 
were found to be equal (fig. S1, E and F). Recovery after vestibular 
disorientation was also examined using the “drop test” (fig. S1, G to 
I). Fish were dropped into a deep tank from 10 cm above the water, 
and time spent at the bottom part of the tank, freezing duration, and 
number of transitions between the top and the bottom of the tank 
were recorded. Wild-type fish tend to first freeze at the bottom, 
then swim at the bottom of the tank, and later explore the top region 
(23). Any deviation from this typical response could indicate vestib-
ular defects. However, no significant differences between wild-type 
and tdp1−/− fish were found in the duration of time spent in the 
bottom area of the tank (fig. S1G), number of transitions between 




Fig. 1. Zebrafish Tdp1 protein and its expression. (A) Schematic structure of 
zebrafish Tdp1 protein, depicting the nuclear localization signal (NLS), phospho-
diesterase domain, and active site histidines H270 and H501 (64). Zebrafish H501 
corresponds to human H493. (B) Alignment of Homo sapiens (hs) and D. rerio (dr) 
TDP1 protein sequence. Identical sequences are highlighted in black, and similar 
sequences are highlighted in gray. The sequence targeted for deletion and catalytic 
HKD motifs [HxK(x)4D(x)6GSxN] with catalytic sites (in red) are noted (64, 65). Yellow 
denotes amino acids that contact the DNA substrate during repair. Accession numbers 
are as follows: hsTDP1, ENST00000335725.8, and drTdp1, ENSDART00000150149.2. 
Sequences were aligned using the Protein BLAST website: https://blast.ncbi.nlm.
nih.gov/Blast.cgi?PAGE=Proteins. (C) Whole-mount in situ hybridization for tdp1 
mRNA in wild-type zebrafish at 24 hpf. Sense probes for tdp1 mRNA were used as a 
negative control.
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To assess whether any ataxic phenotypes were present during 
development, we monitored the photomotor response of 4- and 
5-dpf embryos with and without exposure to the TOP1 inhibitor, 
CPT. On the basis of the known function of tdp1 and observations 
in mice, CPT treatment was expected to exacerbate otherwise mild 
phenotypes (19, 21). Tdp1−/− females were crossed with tdp1−/+ males 
to avoid any maternal contribution of tdp1 mRNA in the progeny. 
The embryos were then treated with 500 nM CPT overnight and 
subjected to 5-min light/5-min dark cycles (Fig. 3, G to J), which 
have been shown to produce a highly robust pattern of larval move-
ment (24–28). Measurement of total distance traveled by the larvae 
at each 5-min cycle (Fig. 3, G and I) and in all light and dark cycles 
combined (Fig. 3, H and J) revealed no significant differences be-
tween tdp1−/− and tdp1−/+ siblings at 4 and 5 dpf.
Adult tdp1−/− zebrafish are hypersensitive to Top1 poisons
TDP1-deficient human, avian, and murine cells, as well as Tdp1−/− 
mice, are hypersensitive to topoisomerase-linked breaks induced by 
CPT and its clinical derivatives, TPT and irinotecan (8, 19, 21, 29). 
To ascertain the role of Tdp1 in zebrafish following exposure to to-
poisomerase 1 poisons, 27-month-old animals were subjected to 
intraperitoneal injections of TPT. The fish received one daily injec-
tion of 22.5 mg/kg for two consecutive days, and their locomotion 
was monitored after each injection and then 24, 48, and 72 hours 
after the second injection (Fig. 4 and fig. S2). Locomotion analysis 
revealed a significant reduction in total distance traveled over 6 hours 
in TPT-treated tdp1−/− fish in comparison to dimethyl sulfoxide 
(DMSO)–injected tdp1−/− fish at 24 (Fig. 4A) and 48 hours (Fig. 4B) 
after the second injection. Likewise, a corresponding decrease of av-
erage speed was found in TPT-treated tdp1−/− fish in comparison to 
DMSO-injected tdp1−/− fish at 24 (Fig. 4C) and 48 hours (Fig. 4D) 
after the second injection. TPT treatment did not significantly affect 
low speed count at 24 hours (Fig. 4E) but markedly reduced it at 
48 hours in TPT-treated tdp1−/− fish, in relation to control tdp1−/− 
fish (Fig. 4F). On the other hand, low speed duration was not al-
tered because of the treatment (Fig. 4, G and H). Medium speed 
count was not affected at 24 hours (Fig. 4I) but strongly reduced at 
48 hours in the TPT-treated tdp1−/− fish in comparison to DMSO- 
injected tdp1−/− fish (Fig. 4J). Likewise, differences in medium speed 
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Fig. 2. Generation and validation of tdp1−/− zebrafish using the CRISPR-Cas9 system. (A) Sequence of oligonucleotide used for guide RNA (gRNA) synthesis. The 
scaffolding sequence is in purple; the target sequence is in green, and the T7 polymerase promoter is in blue. (B) Intron-exon structure of the D. rerio tdp1 gene. Exon 2 
(in red) was targeted for mutation by Cas9; scale bar, 5000 bp. Photo credit: Ringaile Zaksauskaite, University of Sheffield (generated using http://wormweb.org/exonintron). 
(C) Sequences of the target region in tdp1WT zebrafish and two isolated deletion alleles, tdp1SH475 and tdp1SH476. The 5-bp deletion (SH476; light blue box) and the 
4-bp deletion (SH475; green square). (D) Tdp1−/+ zebrafish were crossed and genotyped at adulthood; c2 = 2.941 with two degrees of freedom; two-tailed P value of 
0.5316. (E) Diagram depicting the TDP1 activity assay showing a 5′ labeled oligomer with a 3′-phosphotyrosyl (PY) that is incubated with zebrafish protein lysate. Active 
TDP1 processes the 3′-PY into a phosphate group, resulting in a band shift on a DNA sequencing gel. (F) TDP1 activity assay was performed on 600 ng of lysate from 4-dpf 
embryos. (G) TDP1 activity assay was performed on fin clips from adult zebrafish. LB, lysis buffer control
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Fig. 3. Tdp1−/− fish have a mild locomotion defect in adulthood but not at 4 to 5 dpf. (A to F) Adult zebrafish movement was recorded with a camera system for 6 hours. 
Time spent swimming at low (<30 mm/s) (A), medium (30 to 60 mm/s) (C), and high (E) speeds (60 mm/s or above) and count of times low (B), medium (D), and high (F) 
swimming speeds were plotted. Each of the 18 fish from either genotype was recorded twice (n = 36) and shown as average ± SEM. P values were calculated by two-tailed 
Student’s t test with Holm adjustment for multiple comparisons. (G to J) Four-dpf (G and H) and 5-dpf (I and J) embryos from a single female tdp1−/− and male tdp1−/+ incross 
were subjected to 3 cycles of 5-min darkness and 5-min light using the photomotor response assay. (G and I) Total distance traveled in each cycle was plotted in each data 
point as average ± SEM. P value, two-tailed Student’s t test. (H and J) Total distance traveled in all light or dark cycles was measured. Lines indicate average ± SEM. (I) Total 
distance traveled each cycle was plotted as average ± SEM. P values were calculated using two-tailed Student’s t test. DMSO, dimethyl sulfoxide. *P < 0.05; **P < 0.01.
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Fig. 4. Adult tdp1−/− zebrafish are hypersensitive to TPT. (A to P) Zebrafish (27-month-old) were intraperitoneally injected with TPT (22.5 mg/kg) or DMSO (22.5 mg/kg) 
on two consecutive days for a final concentration of 45 mg/kg and monitored for 1.5 hours using a camera system 24 and 48 hours after the second injection. P values, 
two-tailed Student’s t test with Holm post hoc analysis for multiple comparisons. Total distance traveled (A and B), average speed (C and D), low speed count (E and F), 
low speed duration (G and H), medium speed count (I and J), medium speed duration (K and L), high speed count (M and N), and high speed duration (O and P) were 
quantified after the second injection. (Q) Tissues were dissected from 29-month-old fish and treated with 14 mM CPT for 2 hours and then examined for Top1-CC accumu-
lation using CsCl fractionation and immunoblotting, as described in Materials and Methods. (R) Quantification of (Q); two biologically independent experiments for heart 
and gut and four for brain; for each independent repeat, either four hearts or four guts were pooled. One brain was used for each independent repeat; ±SEM. P values, 
two-tailed Student’s t test. n.s., not significant. *P < 0.05; **P < 0.01.
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not significant until 48 hours after the second injection (Fig. 4, K 
and L). Furthermore, no obvious differences were observed in high 
speed count at 24 hours after treatment (Fig. 4M), while at 48 hours, 
high speed count was reduced in TPT-treated tdp1−/− fish, in relation 
to control tdp1−/− fish (Fig. 4N). High speed duration was signifi-
cantly lower at both the 24- and 48-hour time points in the TPT- 
treated tdp1−/− fish in comparison to DMSO-injected tdp1−/− fish 
(Fig. 4, O and P). All locomotion parameters were also quantified 
72 hours after the second injection, but no significant differences were 
found (fig. S2). To summarize, TPT treatment significantly decreased 
low speed count, medium speed duration, and high speed duration 
and count in tdp1−/− animals at 48 hours after the second injection. 
High speed duration was also lower in TPT-treated tdp1−/− fish than 
in DMSO-treated tdp1−/− fish at 24 hours after the second injection. 
Notably, none of the locomotion parameters were significantly different 
in wild-type siblings before and after treatment at this dose, showing 
that adult tdp1−/− zebrafish are hypersensitive to increased Top1-CCs.
To confirm TPT hypersensitivity in adult tdp1−/− zebrafish, we 
dissected the gut, brain, and heart from 29-month-old fish and 
treated the tissues with CPT (Fig. 4, Q and R). Tissue lysates were 
subjected to cesium chloride fractionation to purify Top1-linked 
DNA breaks. CPT treatment caused a significant increase in Top1-
CCs in the gut of tdp1−/− zebrafish in comparison to their wild-type 
siblings, but there were no significant differences in the brain or 
heart tissues. Increased Top1-CC level in the gut of CPT-treated 
adult tdp1−/− zebrafish is consistent with the observed reduced mo-
bility phenotype after TPT treatment.
Embryonic tdp1−/− zebrafish are not hypersensitive  
to Top1 poisons
We next wondered whether embryonic tdp1−/− zebrafish would also 
be hypersensitive to Top1 poisons. Tdp1−/+ fish were incrossed, and 
the progeny was treated with various concentrations of CPT at 4 dpf 
for 16 hours. As each concentration produced a range of pheno-
types at 5 dpf, the fish exhibiting the most severe phenotypes, such 
as body curvature, brain necrosis, and lack of swim bladder were 
blindly selected and genotyped (Fig. 5A). From previous studies, we 
predicted that the most severely affected embryos should be posi-
tive for tdp1 mutation (19, 21, 30). In notable contrast to our predic-
tion, genotyping revealed a Mendelian distribution of genotypes 
across the selected embryos (Fig. 5B). The lack of hypersensitivity of 
tdp1−/− embryos could be a result of maternal contribution of tdp1 
mRNA. To address this possibility, we repeated this experiment by 
crossing female tdp1−/− fish to male tdp1−/+ fish. Unexpectedly, 
the genotypes blindly selected this way were also consistent with 
Mendelian ratios from such a cross (Fig. 5C). To ascertain whether 
CPT was indeed inhibiting topoisomerase 1 in zebrafish, Top1-CC 
induction in 3-dpf tdp1−/− embryos was measured by cesium chlo-
ride fractionation of lysates into free protein, DNA-protein com-
plexes and free DNA after a 2-hour CPT treatment (Fig. 5, D and E). 
Immunoblotting of fractions with a Top1-CC antibody revealed that 
CPT did induce Top1-CCs in equal levels in tdp1−/− and tdp1WT 
fish. Together, these results suggest that zebrafish embryos, but not 
adults, can tolerate Top1-induced DNA breaks despite Tdp1 loss.
Embryonic tdp1−/− fish do not exhibit increased CPT-induced 
DNA double-stranded breaks
Top1-CCs could be converted into DNA DSBs during replication. 
Therefore, we measured overall and local phosphorylated H2A histone 
family member X (gH2AX) levels in tdp1−/− embryos after CPT and ion-
izing radiation (IR) treatment. IR primarily causes DNA strand breaks 
and base modifications, both of which can trap Top1 on DNA (31, 32). 
First, 4-dpf embryos were treated with CPT overnight and then harvested 
for immunoblotting for gH2AX at 5 dpf (fig. S3, A and B). An induction 
of gH2AX was observed in both genotypes, without a significant increase 
in tdp1−/− embryos. The embryos were also treated with irradiation 
at 24 hpf, and overall gH2AX levels were analyzed by immunoblotting; 
however, similar levels of gH2AX were observed (fig. S3, C and D). 
As the cerebellum is selectively vulnerable in SCAN1 patients and 
mice, local induction of gH2AX foci in the 24-hpf cerebellum and 
optic tectum was also quantified. Embryos (24 hpf) were irradiated 
with 22 gray and fixed either immediately or after a 30-min recov-
ery for immunofluorescence analysis (fig. S3E). Quantification of 
gH2AX foci revealed no significant differences in IR-induced DSBs 
between genotypes in both tissues (fig. S3F).
Tdp1 is dispensable for Top1-CC repair  
in the zebrafish embryo
The hypersensitivity to Top1 poisons in adult zebrafish, but not em-
bryos, suggests the presence of a compensatory pathway during the 
embryonic stages, which could be either overwhelmed or inaccessi-
ble during adulthood. It has been shown that Tdp2 can repair Top1-
CCs in the absence of Tdp1 (33). To investigate the possibility of 
compensation by Tdp2, we treated 4-dpf embryos with 500 nM 
CPT overnight and harvested the embryos for protein and RNA 
analyses. We chose a low dose of CPT (500 nM) for a longer time 
(16 hours) over a shorter pulse with a high dose to observe the long-
term effects on transcription. Embryo lysates were incubated with a 
labeled oligonucleotide with a 5′ phosphotyrosyl moiety, mimicking 
Top2-CCs, and then run on a DNA sequencing gel, where a band 
shift indicates Tdp2 activity. No overt differences were observed 
between wild-type and tdp1−/− embryos (Fig. 6A). The RNA was 
transcribed into cDNA and used for quantitative polymerase chain 
reaction (qPCR) analysis of mRNA levels. Contrary to expectations, 
tdp2b mRNA was significantly reduced in DMSO-treated tdp1−/− 
embryos (Fig. 6B). This difference, however, seemed to be abrogat-
ed by CPT whereby tdp2b mRNA exhibited similar levels in tdp1−/− 
and tdp1WT embryos. Thus, tdp2b is not the responsible compensatory 
factor. We then tested the next most likely compensation candi-
dates mre11a, mus81, ercc1-ercc4, apex2, and rbbp8. These endonu-
cleases have been shown to have the ability for Top1-CC repair in 
mouse, chicken, and yeast cells (34–39). We treated 4-dpf embryos 
with 500 nM CPT overnight for 16 hours and harvested RNA at 5 dpf. 
The RNA was transcribed into cDNA, which was used as a template 
in qPCR (Fig. 6C). Two different primer pairs were used for apex2: 
one targeting both transcript 201 (ENSDART00000021514.7) and 
202 (ENSDART00000189272.1), denoted apex2, and another one 
targeting only one transcript 201, denoted apex2_201. qPCR results 
showed no significant difference in the expression of mre11a, mus81, 
ercc1, ercc4, apex2, and rbbp8 between tdp1−/− and tdp1WT embryos 
both in DMSO- and CPT-treated conditions. However, we did note 
a remarkable increase in apex2 and ercc4 mRNA after CPT treatment in 
both genotypes. There was a significant increase in expression of apex2 
using both primer pairs; however, transcript 201 showed an even higher 
increase than transcripts 201 and 202 together. We also observed that 
CPT treatment resulted in a significant decrease in ercc1 and mus81.
To examine the mechanism/s that enable zebrafish embryos to 
tolerate Tdp1 loss, we conducted microarray analyses comparing gene 
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expression profiles of CPT-treated tdp1−/− and tdp1WT embryos 
(fig. S4). RNA was extracted from 5-dpf embryos after an overnight 
500 nM CPT treatment and processed for microarray investigations. 
Data analysis revealed 1720 transcript clusters that were differen-
tially expressed between tdp1−/− and tdp1WT embryos (fig. S4A, B). 
A total of 1021 of these transcript clusters were up-regulated, and 
699 were down-regulated. As expected, tdp1 was significantly down- 
regulated in tdp1−/− fish (fig. S4C). The top three hits with the lowest 
P value were zinc finger protein 644 (znf644b), si:dkeyp-53e4.4 
(Ensembl accession: ENSDARG00000114935), and CABZ01069162.1 
(Ensembl accession: ENSDARG00000115161). Znf644b and si:dkeyp- 
53e4.4 were up-regulated by 4.88- and 10.13-fold, respectively, while 
CABZ01069162.1 was down-regulated by 6.54-fold. Znf644b is one 
of two genes encoding for the Znf644 transcription factor in zebrafish 
(40). It contains five C2H2 and one atypical zinc finger motif. Znf644 
regulates H3K9-mediated gene silencing during neurogenesis and 
has been linked to autosomal dominant high-grade myopia (40–42). 
Si:dkeyp-53e4.4 and CABZ01069162.1 are uncharacterized fish- 
specific genes. CABZ01069162.1 belongs to the TF613015 PiggyBac 
transposable element-derived family. The expression of sprtn and 
neil1 was significantly increased in tdp1−/− embryos (fig. S4C). Sprtn 
is a DNA-dependent metalloprotease that plays a role in the resolu-
tion of DNA-protein cross-links, including Top1-CCs, while Neil1 
is a glycosylase that participates in the first step of base excision re-
pair (43–46). As sprtn and neil1 were the most likely compensation 
candidates from the microarray screen, we carried out qPCR to 
confirm these hits, as described previously for tdp2b (fig. S4D). 


































































































Blind selection of affected embryos
Healthy No swim bladder
Body curvature No swim bladder
Brain necrosis
Fig. 5. Tdp1 −/− zebrafish embryos are not hypersensitive to CPT. (A) Diagram of blind assay to assess CPT sensitivity showing embryos with severe body curvature or 
brain necrosis or lacking swim bladders. (B) Tdp1−/+ fish were incrossed, and at 4 dpf, sibling embryos were treated with CPT (350, 500, and 750 nM) overnight. At 5 dpf, 
the most strongly affected embryos were blindly selected and genotyped. c2 = 4.902 with two degrees of freedom. The two-tailed P value is equal to 0.0862. (C) A female 
tdp1−/− fish was crossed with a male tdp1−/+ fish, and at 4 dpf, the embryos were treated with 500 and 1 mM CPT overnight. At 5 dpf, most strongly affected siblings were 
blindly selected at each concentration and genotyped. c2 = 0.391 with one degree of freedom. The two-tailed P value is equal to 0.5316. (D) Three-dpf embryos were 
treated with 14 mM CPT for 2 hours; then, TOP1-CC was examined using CsCl fractionation and immunoblotting, as described in Materials and Methods. (E) Quantification 
of (D); three biologically independent experiments, ±SEM. P values, two-tailed Student’s t test.
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in comparison to wild types, both after DMSO and CPT treatment. 
This decrease was only significant for neil1. qPCR also showed a 
significant decrease in neil1 expression after CPT treatment.
The fact that none of the key Top1-CC repair enzymes were 
up-regulated in the tdp1−/− embryos led us to consider the possibil-
ity that Tdp1 is not required for Top1-CC repair at this stage. We 
thus investigated the expression of tdp1 mRNA after incubation 
with CPT. We treated 4-dpf embryos with 500 nM CPT overnight 
for 16 hours and harvested RNA at 5 dpf. As expected, tdp1 mRNA 
was reduced by more than 50% in DMSO-treated tdp1−/− embryos 
in comparison to wild-type siblings (Fig. 6D). To our surprise, how-
ever, tdp1 expression was significantly reduced after incubation 
with CPT, suggesting that tdp1 may not be required for Top1-CC 
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Fig. 6. Tdp1 is not required for Top1-CC repair in zebrafish embryos. (A) Four-dpf zebrafish were treated with 500 nM CPT overnight, and lysates were incubated with 
a 3′ labeled oligonucleotide with a 5′-phosphotyrosyl (PY). TDP2 processes the phosphotyrosyl moiety into a phosphate group, resulting in a lower band on a DNA se-
quencing gel. We noted bands that are higher than the original substrate, which suggest further repair events taking place using the zebrafish lysate. Lysis buffer (LB) was 
used as a negative control and human embryonic kidney (HEK) 293 cell lysate as a positive control. (B to D) Four-dpf zebrafish embryos were treated with 500 nM CPT 
overnight, and total RNA was processed by reverse transcription qPCR (RT-qPCR). Transcript levels normalized to rps29 are shown; three biologically independent exper-
iments, ±SEM. P values, two-way analysis of variance (ANOVA) with Holm post hoc analysis for multiple comparisons. (E) A model for the requirement of distinct DNA re-
pair factors for Top1-CC repair during the zebrafish life span. We propose that during embryonic development, zebrafish use Apex2 and Ercc4 to repair Top1-induced DNA 
breaks. During adulthood, however, Tdp1 becomes essential for repairing Top1-CCs, and thus, tdp1−/− fish develop a mild behavioral defect and CPT hypersensitivity in 
adulthood but not at embryonic stage. *P < 0.05; **P < 0.01; ***P < 0.001; and ****P < 0.0001.
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apex2 was increased following CPT treatment (Fig. 6C). We next 
generated apex2 crispants whereby mosaic mutations are intro-
duced in the target gene using CRISPR-Cas9 to obtain a stable 
knockdown of the protein. A pool of four guide RNAs (gRNAs) 
designed across the apex2 gene was injected before or at the one-cell 
stage. PCR assessment of gRNA efficiency revealed an average 42% 
of detectable mutations (fig. S5, A and B). Treatment of the 4-dpf 
apex2 crispant embryos with CPT revealed no overt morphological 
differences when compared to controls (fig. S5, C and D). In contrast, 
recording embryo movement with a camera followed by quantifica-
tion of the total distance traveled revealed a putative role for apex2 
in response to Top1-CC. Whereas apex2 gRNA injections did not 
affect the movement of DMSO-treated embryos, it significantly re-
duced the total distance traveled in CPT-treated apex2 crispants in 
comparison to CPT-treated controls (fig. S6E). These data suggest a 
role for apex2 in repairing Top1-CCs in zebrafish embryos, which is 
consistent with recently reported in vitro biochemical assays and 
studies in human cells (38, 39), and lay the foundation of further 
validations in follow-up studies.
DISCUSSION
SCAN1 is caused by an active site mutation in TDP1 that leads to 
progressive neurodegeneration. It is thought that neurodegenera-
tion is a combined result of the accumulation of protein-linked DNA 
breaks, a lack of alternative repair pathways, high oxidative stress, 
and transcription levels in postmitotic neurons (47). However, studies 
show that TDP1 is also required in replicating cells under genotoxic 
stress (29, 48, 49). Mouse Tdp1−/− models have been generated in 
attempts to unravel the physiological role of TDP1, but only a few 
mild phenotypes were reported in adult animals, such as a slight re-
duction in brain-to-body ratio and hypoalbuminemia (19–21). No 
overt ataxia was observed. Two groups also generated Drosophila 
melanogaster knockouts of glaikit, a Tdp1 ortholog; however, their 
results were conflicting. Dunlop et al. (50) demonstrated that dele-
tion of glaikit (gkt) in flies leads to defective neurogenesis and, thus, 
embryonic lethality, whereas Guo et al. (30) found that the flies are 
viable with little phenotype other than a decreased life span in fe-
males. As the first group linked their findings to a disruption of 
membrane trafficking and did not directly assess tdp1 activity, it is 
thought that the phenotype is unrelated to tdp1.
Here, we describe the first tdp1 knockout zebrafish. We show 
modest reductions in the number of times adult tdp1−/− fish initiated 
low and medium speeds and the duration of time they spent swim-
ming at medium speed, suggesting a mild behavioral deficiency. 
However, such reductions were only statistically significant in a few 
of the recorded time points, which is likely due to subtle differences. 
Nevertheless, there was a trend of reduced movement throughout 
the analyses. Previous studies also found hypersensitivity to Top1 
poisons or the non-CPT inhibitor NSC-725776 in adult mice and 
flies, which our findings in TPT-treated adult fish corroborate 
(19, 21, 30). We found that most locomotion parameters were sig-
nificantly affected in adult tdp1−/− fish either 24 or 48 hours after 
administering TPT (45 mg/kg). This was concomitant with in-
creased levels of Top1-CCs in the gut of adult tdp1−/− fish in com-
parison with their wild-type siblings after TPT treatment. Although 
we predicted postmitotic tissues, such as the heart and the brain, to 
be predominantly vulnerable to loss of Tdp1, we did not observe 
significant differences in Top1-CC levels in these tissues between 
adult tdp1−/− and tdp1WT fish after CPT treatment. This could be 
due to a preferential effect of acute exposure to CPT in replicat-
ing tissues compared to noncycling tissues (21, 51, 52). We did not 
observe an ataxic phenotype in tdp1−/− larvae, which was not unex-
pected given that patients with SCAN1 do not start showing symp-
toms until late childhood (3). Next, we assessed the sensitivity to 
CPT in embryonic tdp1−/− zebrafish and, notably, found that, in 
contrast to studies in mice, human, and avian cells, tdp1−/− embryos 
were not hypersensitized to CPT. We note that our results here are 
reminiscent of a recent report in plants showing that Arabidopsis 
Tdp1 knockout is also not hypersensitive to TOP1-induced DNA 
damage (53). At the molecular level, there were no differences in 
Top1-CC and gH2AX levels between tdp1−/− and wild-type em-
bryos either before or after CPT or IR treatment, confirming that 
loss of Tdp1 had no measurable effect in embryos, even under chal-
lenging conditions. We have found the lack of CPT sensitivity to be 
corroborated by an unexpected down-regulation of tdp1 mRNA 
after CPT treatment, suggesting that tdp1 is not required to repair 
Top1-CCs in zebrafish embryos. Instead, we show that apex2 and 
ercc4 are up-regulated. While apex2 crispants did not show overt 
morphological differences following CPT treatment, they exhibited 
a significant reduction in total distance traveled. This adds weight 
to the notion that apex2 is responsible for Top1-CC repair in zebrafish 
embryos. Although these findings need further experimental proof 
in follow-up studies, they are consistent with recent reports show-
ing a role for apex2 in TOP1-CC repair. For a while, it has been 
known that the yeast apex2 ortholog apn2 has phosphodiesterase 
activity (53–55). Only recently, it was shown that the vertebrate 
Ape2 has the unique ability to process phosphotyrosine-DNA con-
jugates into readily ligatable DNA ends, which our data corroborate 
(38, 39). Ercc4 would also be an intriguing candidate for Top1-CC 
repair; however, we found ercc1, an essential part of the ercc1-ercc4 
heterodimer, to be slightly down-regulated after CPT treatment. It 
is likely that zebrafish Ercc4 does not require Ercc1 for DNA bind-
ing and activity, which could explain this conundrum. It is reminis-
cent of Ercc4 in archaea, which do not have Ercc1 at all (56). Mus81 
and neil1 were significantly down-regulated as well. This result in-
dicates that, as well as tdp1, these factors are likely not required for 
Top1-CC repair in the zebrafish embryo. Tdp2b, mre11a, and rbbp8 
(ctip) did not show significant expression changes in response to 
increased Top1-CCs, and tdp2 did not show a measurable increase 
in activity. Despite the lack of a phenotype or CPT hypersensitivity 
in tdp1−/− embryos, microarray analysis identified gross tran-
scriptional changes in CPT-treated tdp1−/− embryos in comparison 
to wild types. This included a slight ~1.3-fold increased expression 
of sprtn and neil1 in tdp1−/− embryos. However, qPCR valida-
tion showed a down-regulation in neil1, both before and after CPT 
treatment, and a nonsignificant trend of sprtn down-regulation in 
tdp1−/− embryos.
To summarize, we have generated and extensively characterized 
a tdp1−/− zebrafish mutant, which is hypersensitive to Top1 poisons 
and has a very mild locomotion defect in adulthood. We found that 
Tdp1 in zebrafish embryos does not appear to play a role in Top1-CC 
repair, which is corroborated by the lack of hypersensitivity to Top1 
poisons at this stage. We show that apex2 and ercc4 are up-regulated 
in response of CPT treatment and are, thus, the factors that are most 
likely repairing this type of damage in the zebrafish embryo. Our 
findings are exciting because the lack of Tdp1 requirement to cope 
with Top1 poisons has only been observed in Arabidopsis thaliana 
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(57), thereby identifying the zebrafish embryo as the first vertebrate 
model that does not require Tdp1 to protect from TOP1-mediated 
DNA damage. We propose apex2 and ercc4 (xpf) as primary players 
protecting from TOP1-induced damage in zebrafish embryos and 




Zebrafish (Danio rerio) were housed in the Bateson Centre aquaria 
and fed Artemia or dry food (Gemma Micro, SKRETTING). Zebrafish 
were kept at a constant temperature of 28°C and 14-hour on/10-hour 
off light cycle. All work were performed in accordance with the U.K. 
Home Office Animals (Scientific Procedures) Act 1986 under personal 
license I023015BA held by R.Z. and project licenses PB2866EDO 
and PC39B259E held by F.v.E.
Whole-mount in situ hybridization
Whole-mount in situ hybridization was carried out as previously 
described (58). A probe of 1030 bp was amplified with KOD Hot 
Start DNA polymerase (Merck, 71086) from zebrafish cDNA using 
primers listed in Table 1, according to the manufacturer’s instruc-
tions. The thermocycling conditions were as follows: 95°C for 3 min, 
followed by 30 cycles of 95°C for 20 s, 53°C for 10 s, and 70°C for 
45 s, finished with 5 min at 70°C. The products were run on a 2% 
agarose gel, and required bands were extracted using the QIAquick 
Gel Extraction Kit (QIAGEN, 28704). To increase the DNA con-
centration, a second round of PCR was carried out. A 20-ml tran-
scription reaction was set up using 2 ml of the final PCR product, 1× 
DIG-UTP (digoxigenin-uridine triphosphate) labeling mix (Roche, 
000000011277073910), 10 U of T7 or T3 RNA polymerase (Promega, 
P207B, P208C), 1× polymerase buffer, and 40 U of RNaseOUT RNase 
inhibitor (Invitrogen, 10777019). The reaction was incubated at 37°C 
for 2 hours. The sample was treated with 2 U of TURBO DNase (Life 
Technologies, AM1354) for 20 min at 37°C. Electrophoresis was carried 
out to confirm whether an intact full-length transcript has been synthe-
sized. The RNA was then precipitated using ammonium acetate. 
Embryos (24 hpf) were dechorionated and fixed in 4% paraformal-
dehyde (PFA) in phosphate-buffered saline (PBS) at 4°C overnight 
and then washed in PBSTw (0.1% Tween 20 in PBS) three times for 
5 min. The embryos were then washed through a series of methanol: 
PBSTw washes of 5 min in each of 25, 50, 75, and 100% methanol in 
PBSTw and stored at −20°C overnight. The embryos were then re-
hydrated back into PBSTw in the same series in reverse and then 
subjected to four 5-min washes in PBSTw. The embryos were treat-
ed with proteinase K (10 mg/ml) for 20 min, which was then 
quenched by two washes with glycine (2 mg/ml) in PBSTw for 5 min. 
Embryos were fixed in 4% PFA in PBSTw again for 20 min at room 
temperature and washed five times for 5 min in PBSTw with shaking. 
Embryos were washed in 50% Hybe−/− [50% formamide, 5× SSC 
(ChemCruz, SC296419), 9.2 mM citric acid, and 0.1% Tween 20 
(pH 6)] in PBSTw for 5 min and then prehybridized in Hybe+/+ 
[50% formamide, 5× SSC, 9.2 mM citric acid, 0.1% Tween 20, tRNA 
(0.5 mg/ml; Invitrogen, 15401029), and heparin (0.05 g/ml)] at 
65°C for at least 1 hour. The pre-Hybe solution was then replaced 
with 1:200 dilution of the probe in Hybe+/+, and the sample was in-
cubated at 65°C overnight. The Hybe solution was aspirated while 
maintaining the tubes at 65°C. The following 10-min washes at 
65°C were carried out: 100% Hybe−/−, 75% Hybe in 2× SSCTw (0.1% 
Tween 20 in 2× SSC), 50% Hybe in 2× SSCTw, 25% Hybe in 
2× SSCTw, and 100% 2× SSCTw. The embryos were then washed 
four times for 15 min in 0.2× SSCTw. The following 5-min washes were 
executed: 75% 0.2× SSC in MABTw [0.1 M maleic acid, 0.15 M NaCl, 
and 0.1% Tween 20 (pH7.5)], 50% 0.2× SSC in MABTw, 25% 
0.2× SSC in MABTw, and 100% MABTw. The embryos were blocked 
in 2% Blocking Reagent (Roche, 11096176001) in MABTw for at 
least 1 hour at room temperature with gentle shaking. The blocking 
buffer was then replaced with a 1:5000 dilution of a-DIG antibody 
(Table 2) in blocking buffer, and the sample was incubated overnight 
at 4°C with gentle rocking. Following this, the sample was rocked 
for 1 hour at room temperature to complete the antibody reaction. 
The sample was then washed eight times for 15 min in MABTw with 
gentle rocking. Embryos were equilibrated in BCL3 developing buf-
fer [100 mM tris (pH 9.5), 100 mM NaCl, 50 mM MgCl2, and 0.1% 
Tween 20] three times for 5 min at room temperature. The develop-
ing buffer was then aspirated and replaced with 50% BM Purple 
(Roche, 11442074001) in BCL3. The staining was developed by 
gently rocking the embryos at room temperature in tubes wrapped 
in foil until desired levels of staining were achieved. The reaction 
was terminated by replacing the BM Purple solution with BCL3 
buffer and then fixing in 4% PFA in PBS at least overnight at 
4°C. For imaging, samples were washed in a series of 5-min washes: 
three times in PBSTw, once in 25% glycerol (Invitrogen, 15514-
011) in PBSTw, once in 50% glycerol in PBSTw, and once in 70% 
glycerol in PBSTw. The embryos were imaged on the Leica M165 
FC dissecting microscope with the Leica Application Suite version 
4.3.0 program.
Generation of tdp1−/− zebrafish
CRISPR-Cas9 was performed as described by Hruscha et al. (59). 
Single-cell stage embryos were injected with 2.4-mg Cas9 mRNA 
and single gRNA (sgRNA; 0.4 mg/ml), targeting the first coding exon 
of zebrafish tdp1 (Table 3), and raised. Cas9 mRNA was in vitro 
transcribed from 1 to 2 mg of Not1-linearized pCS2-nCas9n plas-
mid using the mMESSAGE mMACHINE kit (Life Technologies, 
AM1340), while sgRNA was transcribed with the MEGAshortscript 
T7 Transcription Kit (Life Technologies, AM1354), according to 
the manufacturer’s instructions. Once the injected animals reached 
sexual maturity, they were outcrossed to wild-type fish, and the 
Table 1. List of whole-mount in situ hybridization primers used in this study.  
Target Oligo (uppercase, gene-specific sequence) F/R Tm (°C) Template Product size 
(bp)
Tdp1 taatacgactcactatagggAGCAGTATCCGCCAGAATTT F 64.6 cDNA 1030
aattaaccctcactaaaggTGGTCTCAGCAGCTCAAGAA R 64.9
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progeny were sequenced to identify founders carrying the desired 
mutations. The selected founders were outcrossed to a wild-type 
strain to generate tdp1−/+ zebrafish, which were later incrossed to 
give rise to tdp1−/− zebrafish. The line was maintained in a mixed 
London wild-type/nacre background.
TDP1 activity assay
TDP1 activity assay was performed similarly to the protocol de-
scribed by Meisenberg et al. (60). Embryos (4 dpf) were anesthe-
tized and deyolked in ice-cold PBS by pipetting up and down with a 
200-ml pipette tip. The embryos were then washed twice in PBS, 
homogenized with a micropestle, and lysed in lysis buffer [200 mM 
Hepes, 40 mM NaCl, 2 mM MgCl2, 0.5% Triton X-100, and 1× pro-
tease inhibitor cocktail (Roche, 4693159001)] for 30 min on ice. The 
fin clips were collected, snap-frozen, homogenized, and lysed in lysis 
buffer. The tissue debris was pelleted at 13,300 rpm for 15 min at 4°C, 
and the supernatant was collected. Ten to 600 ng of total protein were 
combined with 1× assay buffer [25 mM Hepes (pH 8.0), 130 mM KCl, 
and 1 mM dithiothreitol (DTT)] and 2.5 mM (embryos) or 60 nM (fin 
clips) Cy5.5-labeled substrate oligomer containing a 3′-phosphotyrosyl 
group (Table 4) in a total volume of 10 ml. The reaction was incubated 
at 37°C for 1 hour and stopped by the addition of 1× loading buffer 
(44% deionized formamide, 2.25 mM tris-borate, 0.05 mM EDTA, 
0.01% xylene cyanol, and 1% bromophenol blue) and boiling at 90°C 
for 10 min. The sample was then loaded onto a prerun 20% Urea 
SequaGel (Fisher Scientific, EC-833-1) and subjected to 150-V elec-
trophoresis for approximately 1 hour. The bands were imaged using 
the ChemiDoc MP imaging system (Bio-Rad, 1708280).
Locomotion analysis
All zebrafish locomotion analysis was carried out in the Sheffield 
Zebrafish Screening Unit. During the photomotor response analy-
sis one 5-dpf embryo was added per well of a 24-well plate and ac-
climatized to the room for 30 min before habituation in 10% light in 
the ZebraBox Viewpoint system. The larval movement was then 
recorded during 3 cycles of 5-min darkness (0% light) and 5-min 
light (10% light) using ZebraLab version 3.20.5.3 software. Adult 
zebrafish locomotion of up to 10 animals at a time was measured in 
the ZebraCube (Viewpoint). The data from the first 30 min (TPT/
DMSO intraperitoneal injections) or 1 hour (untreated fish move-
ment) were removed to account for acclimatization and were ana-
lyzed using ZebraLab software version 3.22.3.9.
Table 2. Antibodies. Species reactivity, host species, supplier, working concentration, and application of primary antibodies. WB, Western blot; SB, slot blot; ISH, 
in situ hybridization; IgG, immunoglobulin G; HRP, horseradish peroxidase. 
Antibody Species reactivity Host species Supplier (catalog no.) Concentration Application
DIG – Sheep Roche (11093274910) 1:5000 ISH
Top1-CC Human, zebrafish Mouse Merck (MABE1084) 1:2000 SB
b-Actin Human, zebrafish Mouse Sigma-Aldrich (A5316) 1: 2000 WB
g-H2AX (Ser139) Zebrafish Rabbit GeneTex (GTX127342) 1: 500 WB
IgG (H + L)–HRP 
conjugate
Mouse Goat Bio-Rad (170-6516) 1:4000 WB
IgG (H + L)–HRP 
conjugate
Rabbit Goat Bio-Rad (170-6522) 1:2000 to 1:4000 WB
Table 3. gRNA used in this manuscript.  
Target Sequence Source















Table 4. TDP1 and TDP2 activity assay oligonucleotides.  
Activity assay Sequence Labels/modifications Source
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Swim tunnel analysis was adapted from the work of Plaut (61). 
Adult zebrafish were habituated in the experiment room for 1 hour 
before being placed in a transparent water tunnel. The water flow 
rate in the tunnel was then gradually increased to 6.58 cm/s, main-
tained for 5 min, and increased in increments of 6.58 cm/s for 5 min 
at a time until the animals got tired and fell into a mesh at the end 
of the tunnel. The fish were allowed a second attempt at swimming 
by reducing the flow rate and then gradually increasing it to the fa-
tigue flow rate for the remainder of the 5-min interval. If the fish got 
tired again, then the time was recorded when they fell into the mesh. 
Critical swimming speed, Ucrit, was calculated using the formula 
Ucrit = Ui + (Uii*Ti/Tii), where Ui is the highest flow rate sustained 
for a complete 5-min interval (cm/s), Uii is the flow rate increment 
(6.58 cm/s), Ti is the time elapsed at the fatigue flow rate (minutes), 
and Tii is the interval of time (5 min).
Intraperitoneal injections of TPT
Zebrafish were kept in groups of seven to nine and fasted 24 hours 
before injection. They were anaesthetized with MS-222 (Sigma- 
Aldrich) and injected intraperitoneally using an insulin syringe 
with a 30-gauge needle (Bunzl Healthcare, 324826) with TPT hydro-
chloride (Sigma-Aldrich) or 30% DMSO in sterile Hank’s buffered 
solution (Gibco, 11530476). A daily dose of TPT hydrochloride 
(22.5 mg/kg) was injected for two consecutive days for a final con-
centration of 45 mg/kg in a total volume of 10 ml.
Measurement of Top1-CCs by fractionation
In vivo complex of enzyme assay was used to purify and quantify 
Top1-CCs, according to Chiang et al. (62). Thirty to 40 3-dpf zebrafish 
embryos or tissues were homogenized and lysed in 1.1-ml lysis buf-
fer [8 M guanidine hydrochloride, 30 mM tris-HCl (pH 7.5), 10 mM 
EDTA, and 1% sarkosyl (pH 7.5)] for 15 min at 65°C. One-milliliter 
aliquots of cesium chloride (CsCl) in a range of densities were gen-
tly layered on top of each other to form a gradient (from bottom to 
top: 1.45, 1.5, 1.72, and 1.82 g/ml) in a 5-ml polyallomer centrifuge 
tube (Beckman, 326819). The lysate was centrifuged at 16,000g for 
10 min; then, 1 ml of the supernatant was carefully layered on top of 
the CsCl gradient. The layered sample was centrifuged at 30,000 rpm 
in a Beckman Ultima LE-80K ultracentrifuge with a swinging rotor 
for 24 hours at 25°C and stopped gradually without a brake. In the 
meantime, 10 ml of the remaining lysate was made up to 100 ml in 1× 
TE buffer [10 mM tris and 1 mM EDTA (pH 8)] and incubated with 
Table 5. RT-qPCR probes.  
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RNase A (ribonuclease A; 0.5 mg/ml) at 37°C overnight. Fifty micro-
liters of the RNase-digested sample or 1× TE buffer was mixed with 
an equal volume of 1× TE buffer with a 1:200 dilution of PicoGreen 
(Invitrogen, P7581). l DNA standard (5 mg/ml) was also mixed with 
1× TE buffer with PicoGreen, and a serial dilution was carried out 
to obtain a range of DNA standards (125 ng to 5 mg). DNA concen-
tration was quantified in a FLUOstar Omega microplate reader 
(BMG) with fluorescence at EX485-12/EM520. Fractionated lysates 
were collected by piercing the bottom of the tube with a 19-gauge 
syringe needle (positioned at 45° with the bevel upward), connected 
to a Pharmacia Biotech P-1 peristaltic pump with a silicone tube. 
Each sample was collected in 10 fractions of 0.5 ml. Fractions with 
equal double-stranded DNA amounts between samples (maximum, 
200 ml) were subjected to slot blotting onto a PBS-wetted 0.45-mm 
nitrocellulose membrane (GE Healthcare, 106000002). The mem-
brane was air-dried and subjected to immunoblotting with a 1:2000 
dilution of a Top1-CC antibody (Table 2).
Western blotting
Zebrafish embryos were deyolked by trituration in PBS, then ho-
mogenized, and lysed in 1 to 1.5 ml of lysis buffer [200 mM Hepes, 
40 mM NaCl, 2 mM MgCl2, 0.5% Triton X-100, and 1× protease 
inhibitor cocktail (Roche)] per embryo. Total protein concentration 
was determined using Bradford reagent (Bio-Rad); then, 100 mg per 
lane were run on a 15% SDS–polyacrylamide gel electrophoresis gel 
and transferred onto a 0.45-mm nitrocellulose membrane (Bio-Rad, 
170-4271) using the Trans-Blot Turbo Transfer System (Bio-Rad, 
17001915), according to the manufacturer’s instructions. The nitro-
cellulose membrane was blocked in blocking buffer [5% milk, 200 mM 
tris, 140 mM NaCl, and 0.1% Tween 20 (pH 7.4)] for 1 hour at room 
temperature and then incubated at 4°C overnight with the primary 
antibody in blocking buffer. The membrane was then washed three 
times for 5 min in 1× TBST buffer [200 mM tris, 140 mM NaCl, and 
0.1% Tween 20 (pH 7.4)] and incubated for 1 hour with horseradish 
peroxidase–conjugated secondary antibody in blocking buffer at 
room temperature. The three washes were repeated before adding 
the Clarity Western ECL blotting substrate (Bio-Rad, 1705060) onto the 
membrane. Bands were visualized in the ChemiDoc MP imaging 
system (Bio-Rad, 1708280) and quantified using Image Lab version 
4.1 (Bio-Rad) software. Details of antibodies are provided in Table 2.
TDP2 activity assay
Cy5.5-labeled substrate oligomer (100 pmol) was combined with 
100 pmol of a 20-bp complementary oligonucleotide with a 5′ over-
hang in a total volume of 33.3 ml (Table 4). The sample was denatured 
at 95°C for 5 min and reannealed by dropping the temperature by 
2°C/s for 5 s and then by 0.1°C/s for 600 s. Once annealed, 3 mM 
double-stranded substrate oligomer with a 5′ overhang was generated. 
We hypothesized that such a substrate should prevent ligation of prod-
uct by zebrafish RNA ligases and, thus, undesirable full repair. Zebrafish 
were deyolked and lysed as described for the TDP1 activity assay. A 
total of 0.5, 1, and 5 mg of the lysate were combined with 1× TDP2 ac-
tivity assay buffer [5 mM tris (pH 7.5), 5 mM KCl, 0.1 mM DTT, bovine 
serum albumin (10 mg/ml), and 0.1 mM MgCl2], 60 nM Cy5.5-labeled 
substrate oligomer, and 2 mM competitor oligo. The bands were im-
aged using the ChemiDoc MP imaging system (Bio-Rad, 1708280).
Reverse transcription qPCR
Thirty-five to 45 zebrafish embryos were homogenized in TRIzol 
reagent (Invitrogen), and total RNA was extracted, according to the 
manufacturer’s instructions. The NanoDrop (Thermo Fisher Scientific) 
was used to quantify RNA; then, 1 mg of RNA was reverse- transcribed 
using the High-Capacity cDNA Reverse Transcription Kit (Applied 
Biosystems). cDNA from all conditions was pooled, serially diluted 
to 20, 4, 0.8, and 0.16%, and run alongside unknown samples to serve 
as a standard curve for extrapolating the sample concentration. Two 
microliters of a 1:16 dilution of individual cDNA was used in a 20-ml 
qPCR reaction with SensiMix SYBR no-ROX master mix (Bioline) 
in a Rotor-Gene 6000 real-time thermocycler (Corbett Research) 
under the following conditions: 95°C for 10 min, followed by 40 to 
45 cycles of 95°C for 15 s, 55°C for 15 s, and 72°C for 15 s (Table 5). 
All samples were run in duplicate and normalized to rps29. Quanti-
fication was performed using the Rotor- Gene Q version 2.3.5 soft-
ware. Primer sequences and other details are listed in Table 5.
Microarray
Zebrafish embryos were homogenized in TRIzol reagent (Invitrogen) 
to extract RNA, according to the manufacturer’s protocol. RNA was 
then sent to the Affymetrix Microarray Core Facility at the University 
of Sheffield. There, samples were processed using the Affymetrix WT 
plus protocol. Total RNA (200 ng) was taken forward to biotin labeling. 
Samples were hybridized using the Affymetrix standard protocol and 
the hybridization, wash, and stain solutions. Hybridization was carried 
out overnight at 45°C for 16 hours in a rotating hybridization platform. 
Post-hybridization stringency washing was performed using the Affy-
metrix fluidics station, following the protocol outlined in the Affymetrix 
instructions. The samples were scanned on an Affymetrix GeneChip 
Scanner 3000, according to the manufacturer’s protocols. Raw data were 
processed and Robust Multi-array Average (RMA) normalized using 
the Transcriptome Analysis Console version 4.0 (Applied Biosystems).
Apex2 crispants
Wild-type embryos at one-cell stage and under were injected with a 
pool of four gRNAs against genomic apex2 (Table 3). Each embryo 
was injected with 1 nl of a solution containing of 2.5 fmol of each gRNA 
(total, 10 fmol), 10 fmol of Cas9 protein (NEB, M0386), and 10 fmol of 
trans-activating CRISPR RNA (tracrRNA). gRNA efficiency was deter-
mined by PCR on DNA extracted from single embryos. DNA extraction 
was carried out using the HotSHOT DNA isolation method. A total of 
25 ml of 1× base solution (1.25 M KOH crystals and 10 mM EDTA) was 
added to each embryo and incubated for 30 min at 95°C. Tubes were 
vortexed, and 25 ml of 1× neutralization solution (2 M tris-HCl in 
Table 6. apex2 genotyping primers.  
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Milli-Q water) was added before vortexing again; the DNA was kept 
on ice. The solution was centrifuged for 2 min at 4200 rpm. PCR 
was carried out using primers listed in Table 6. Embryo images were 
taken using the Leica M165 FC dissecting microscope with Leica 
Application Suite version 4.3.0; total distance traveled was quanti-
fied using ImageJ, as described by Meijering et al. (63), after cor-
recting for camera movement.
Statistical analyses
For adult behavioral analysis, n = 36 corresponds to each of the 
18 fish recorded twice. P values were calculated using two-tailed 
Student’s t test with Holm adjustment for multiple comparisons. 
For embryonic behavioral analysis, P values were calculated be-
tween tdp1−/− and tdp1−/+ pairs from n = 39 (4 dpf) or n = 14 (5 dpf) 
for tdp1−/+ DMSO, n = 49 (4 dpf) or n = 25 (5 dpf) for tdp1−/− 
DMSO, n = 43 (4 dpf) or n = 15 (5 dpf) for tdp1−/+ CPT, and n = 45 
(4 dpf) or n = 22 (5 dpf) for tdp1−/− CPT using a two-tailed Student’s 
t test with Holm adjustment for multiple comparisons. In the swim 
tunnel test, n = 6 and the P value for the “survival” curve was calcu-
lated using the Mantel-Cox test, while for the Ucrit, weight, and 
length parameters, a two-tailed Student’s t test was used; for the 
drop test (n = 8), P values were calculated by two-tailed Student’s 
t test. For intraperitoneal TPT injections, n = 7 for TPT-treated and 
DMSO-treated tdp1WT and DMSO-treated tdp1−/−, while n = 8 for 
TPT-treated tdp1−/−. P values were calculated using two-tailed Stu-
dent’s t test with Holm post hoc analysis for multiple comparisons; 
for the blind CPT sensitivity assay in embryos, n = 40 for tdp1−/+ 
incross and n = 23 for the tdp1−/− and tdp1−/+ cross. A chi-square 
test was used to calculate two-tailed P value; for Top1-CC quan-
tification and Western blots, P values were calculated from three 
biologically independent experiments with two-tailed Student’s 
t test. For gH2AX, n = 8 for all untreated conditions, n = 10 for IR0 
tdp1WT cerebellum, n = 8 for IR0 tdp1−/− cerebellum, n = 8 for IR0 
tdp1WT optic tectum, n = 9 for IR0 tdp1−/−optic tectum, n = 5 for 
IR30 tdp1WT cerebellum and optic tectum, and n = 4 for IR30 
tdp1−/− cerebellum and optic tectum. qPCR results were quantified 
from three biological repeats and normalized to rps29. P values were 
derived from performing two-way analysis of variance (ANOVA) 
with Holm post hoc analysis for multiple comparisons. The micro-
array experiment was performed on samples from three biologically 
independent experiments, and results were processed using the 
Transcriptome Analysis Console version 4.0 with default analysis 
settings, except for fold change (<−1.2 or >1.2). The apex2 crispant 
movement analysis was performed on n = 33 for control uninjected 
DMSO-treated embryos, n = 47 for control uninjected apex2 
crispants, n = 35 for control uninjected CPT-treated embryos, and 
n = 39 for CPT-treated apex2 crispants; P values were calculated 
using two-way ANOVA with Sidak post hoc analysis. All values 
were plotted ±SEM. P values are indicated as follows: not signifi-
cant, P > 0.05; *P < 0.05; **P < 0.01; ***P < 0.001; and ****P < 0.0001.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/7/5/eabc4165/DC1
View/request a protocol for this paper from Bio-protocol.
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